Resistance is common in paediatric patients failing ART in South Africa

Background Minimal data exist on HIV drug resistance patterns and prevalence among paediatric patients failing ART in resource-limited settings. We assessed levels of HIV drug resistance in children with virological failure. Methods This cross-sectional study, performed from March 2017 to March 2019 in South Africa, enrolled HIV-positive children aged <= 19 years, receiving ART through public health facilities with recent evidence suggestive of virological failure (at least one viral load >= 1000 copies/mL), across 45 randomly selected high-volume clinics from all nine provinces. Resistance genotyping was performed using next-generation sequencing technologies. Descriptive analysis taking into account survey design was used to determine outcomes. Results Among 899 participants enrolled, the adjusted proportion of HIV drug resistance among children with virological failure was 87.5% (95% CI 83.0%-90.9%). Resistance to NNRTIs was detected in 77.4% (95% CI 72.5%-81.7%) of participants, and resistance to NRTIs in 69.5% (95% CI 62.9%-75.4%) of participants. Overall, resistance to PIs was detected in 7.7% (95% CI 4.4%-13.0%) of children. Conclusions HIV drug resistance was highly prevalent in paediatric patients failing ART in South Africa, with 9 in 10 patients harbouring resistance to NNRTIs and/or NRTIs. PI-based regimens are predicted to be highly efficacious in achieving virological suppression amongst patients failing NNRTI-based regimens. Scaling up resistance testing amongst patients would facilitate access to second- and third-line regimens in South Africa.

Automated summary

HIV drug resistance is highly prevalent among paediatric patients failing ART in South Africa, with 90% of patients harbouring resistance to NNRTIs and/or NRTIs. Scaling up resistance testing would facilitate access to second- and third-line regimens in South Africa.